Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $57.4 million.

  • Treace Medical Concepts' Cash & Current Investments fell 3065.62% to $57.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.4 million, marking a year-over-year decrease of 3065.62%. This contributed to the annual value of $75.7 million for FY2024, which is 3857.29% down from last year.
  • Per Treace Medical Concepts' latest filing, its Cash & Current Investments stood at $57.4 million for Q3 2025, which was down 3065.62% from $69.3 million recorded in Q2 2025.
  • Treace Medical Concepts' Cash & Current Investments' 5-year high stood at $170.7 million during Q1 2023, with a 5-year trough of $16.2 million in Q1 2021.
  • Over the past 5 years, Treace Medical Concepts' median Cash & Current Investments value was $98.5 million (recorded in 2022), while the average stood at $97.0 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 106080.54% in 2021, then plummeted by 3857.29% in 2024.
  • Treace Medical Concepts' Cash & Current Investments (Quarter) stood at $105.8 million in 2021, then fell by 23.23% to $81.3 million in 2022, then surged by 51.62% to $123.2 million in 2023, then tumbled by 38.57% to $75.7 million in 2024, then decreased by 24.13% to $57.4 million in 2025.
  • Its last three reported values are $57.4 million in Q3 2025, $69.3 million for Q2 2025, and $76.1 million during Q1 2025.